From investors' perspective, the prognosis is really good here [in the pharmaceuticals sector].

What happened when Warner merged with Pfizer in the end of May is that you will have a much broader portfolio. You will have probably 10 different drugs growing at double-digit rates. One of the advances of this merger is to broaden the focus beyond just the two drugs.

Adversity always hides a gift.

It is easy to assume that others want the same thing you want.

Deception of perspective usually starts when you re-educate between the lines to know whats not told is what should of been

Challenge is not with out its own rewards